Company: DMAC
Filing Date: 2025-05-15
Form Type: 8-K
Source: 0001437749-25-017239
Chunk: 2

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-05-15
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01

Financial Statements and Exhibits.

  (d)      Exhibits.  

  Exhibit No.      Description                                                                    
 ──────────────────────────────────────────────────────────────────────────────────────────────────
          104      The Cover Page from this Current Report on Form 8-K, Formatted in Inline XBRL  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  DIAMEDICA THERAPEUTICS INC.                                             
  By:                              /s/ Scott Kellen                       
                                   Scott Kellen                           
                                   Chief Financial Officer and Secretary  

Date:May 15, 2025